December 10, 2013
Ethical drug sales in October crept up 2.5% from a year before, according to a flash report released by Crecon Research & Consulting. The uptick apparently stemmed from bullish sales of dipeptidyl peptidase-4 (DPP-4) inhibitors, while the performance of influenza...read more